Publications by authors named "Laura Brunner"

Claim this Profile
C
Comparison of RT-qPCR With Branched DNA to Quantify a Lipid Nanoparticle-Encapsulated mRNA Therapeutic in Serum and Liver Tissue Samples From Nonclinical PK Studies.
Jessica Ortiz, Laura Brunner, Lei Ci, Rena Baek, Darshana Jani

AAPS J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
Rosalyn Singleton, Sara Rutz, Gretchen Day, Melissa Hammes, Amy Swango Wilson, Laura Brunner

J Addict Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Research and policy priorities for addressing prenatal exposure to opioids in Alaska.
Rosalyn Singleton, Amanda Slaunwhite, Mary Herrick, Matthew Hirschfeld, Laura Brunner

Int J Circumpolar Health· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a ligand binding assay using dried blood spot sampling.
Daniel Burns, Laura Brunner, Surendran Rajendran, Beth Johnson, Mark Ma

AAPS J· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based strategy for bioanalytical method comparison: measurement of a soluble ligand as a biomarker.
Theingi M Thway, Jin Wang, Laura A Brunner, Wen Gu, Ivan Magana

J Pharm Biomed Anal· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to minimize variability and bias associated with manual pipetting in ligand binding assays to assure data quality of protein therapeutic quantification.
Kinnari Pandya, Chad A Ray, Laura Brunner, Jin Wang, Jean W Lee

J Pharm Biomed Anal· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalytical method requirements and statistical considerations in incurred sample reanalysis for macromolecules.
Theingi M Thway, Chris R Macaraeg, Dominador Calamba, Laura A Brunner, Michael Eschenberg

Bioanalysis· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Fit-for-purpose" method validation and application of a biomarker (C-terminal telopeptides of type 1 collagen) in denosumab clinical studies.
Jin Wang, Jean Lee, Daniel Burns, David Doherty, Laura Brunner

AAPS J· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis